Spotlight on the treatment of ALK-rearranged non-small-cell lung cancer.

Files
lmt-06-125.pdf (508.7 KB)
If you need an accessible version of this item, please email your request to digschol@iu.edu so that they may create one and provide it to you.
Date
2017-12
Authors
Mamdani, Hirva
Jalal, Shadia I.
Language
American English
Embargo Lift Date
Department
Medicine, School of Medicine
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Future Medicine
Abstract
Description
Keywords
ALK rearrangement, Alectinib, Brigatinib, Ceritinib, Crizotinib, Molecularly targeted therapy, Non-small-cell lung cancer
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Mamdani, H., & Jalal, S. I. (2017). Spotlight on the treatment of ALK-rearranged non-small-cell lung cancer. Lung cancer management, 6(4), 125–128. doi:10.2217/lmt-2018-0004
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Lung Cancer Management
Rights
Publisher Policy
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
https://hdl.handle.net/1805/19847
DOI
https://doi.org/10.2217/lmt-2018-0004
Version
Full Text Available at
This item is under embargo {{howLong}}
Collections
Open Access Policy Articles
Department of Medicine Works